Richard J. Massey to Retire From BioVeris
20 Julho 2005 - 7:00PM
PR Newswire (US)
Richard J. Massey to Retire From BioVeris GAITHERSBURG, Md., July
20 /PRNewswire-FirstCall/ -- BioVeris Corporation (NASDAQ:BIOV)
announced today that Dr. Richard J. Massey is retiring from his
position as the Company's President and Chief Operating Officer,
effective August 1, 2005. Dr. Massey will remain on the Company's
Board of Directors. In honor of his many contributions to the
Company, BioVeris is naming its research and development facility
after Dr. Massey. Samuel J. Wohlstadter, the Company's Chief
Executive Officer, will assume Dr. Massey's responsibilities. "In
my 22 year career at BioVeris and its predecessor, I truly enjoyed
working with a group of individuals who have dedicated their lives
to improving the health of the general population," said Dr.
Massey. "BioVeris has a proud history in the healthcare field, and
I am honored to have been a part of it. I have great confidence in
the management team and all of the talented employees at BioVeris,
and I believe they will continue to build on the Company's
successes." "Richard's commitment to the business is a legacy that
will continue at BioVeris," said Mr. Wohlstadter. "We are proud to
have the honor to name our research and development facility the
Richard J. Massey Research and Development Center." BioVeris
Corporation is a global integrated health care company developing
proprietary technologies in diagnostics and vaccinology. The
Company is dedicated to the commercialization of innovative
products and services for healthcare providers, their patients and
their communities. BioVeris is headquartered in Gaithersburg,
Maryland. More information about the Company can be found at
http://www.bioveris.com/. DATASOURCE: BioVeris Corporation CONTACT:
George Migausky of BioVeris Corporation, +1-301-869-9800, ext.
2013, Investors: Jonathan Fassberg of The Trout Group,
+1-212-477-9007, ext. 16, or Media: Paul Caminiti or Andrew Cole of
Citigate Sard Verbinnen, +1-212-687-8080 Web site:
http:/www.bioveris.com
Copyright
BIOVENTUS INC. (NASDAQ:BIOV)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
BIOVENTUS INC. (NASDAQ:BIOV)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Bioventus Inc. Class A Common Stock (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Bioveris (MM)